A 64-year-old with T2D and ASCVD on metformin seeks additional therapy. Which combination aligns with ADA recommendations for maximal CV risk reductio...

Question

A 64-year-old with T2D and ASCVD on metformin seeks additional therapy. Which combination aligns with ADA recommendations for maximal CV risk reduction?

Accepted Answer

Add SGLT2 inhibitor or GLP-1 RA with CV benefit

Answer

Add sulfonylurea only

Answer

Add basal insulin only

Answer

Add DPP-4 inhibitor

Answer

No addition needed

"us-abfm MCQ (SBA): T2D with ASCVD

A 64-year-old with T2D and ASCVD on metformin seeks additional therapy. Which combination aligns with ADA recommendations for maximal CV risk reduction?